WASHINGTON, D.C.—The workforce shortage in rheumatology is a looming crisis that demands immediate attention. The ACR’s 2015 Workforce Study projected that by 2030, the supply of adult rheumatologists would dwindle by 31%, in contrast to the increase in demand by close to 138%.1 The situation is even worse for pediatric rheumatology and in rural and…
Occupational therapist Cheryl Crow, who lives with rheumatoid arthritis, shares the ins and outs of what OT is and how it can help those with rheumatic conditions.
Dr. Elizabeth Hazel reflects on her experience as a Canadian swimming competitor in the 1992 Summer Olympics.
Dr. David D’Cruz’s research attempts to help patients make sense of chronic nightmares, an understudied symptom of lupus.
In an effort to ameliorate serious rheumatology provider shortages, the ACR Workforce Solutions Committee has developed a new resource for primary care providers who treat patients with rheumatic conditions.
Why was this study done? Juvenile dermatomyositis (JDM) is the most common type of idiopathic inflammatory myopathy in childhood, and most patients have a chronic disease course requiring prolonged administration of systemic glucocorticoids and immunosuppressive agents. The initial management for patients with moderately severe JDM is relatively standardized, typically including methotrexate and systemic glucocorticoids with…
“While our group carefully considered your application, I regret to inform you that you were not selected this year to serve as a committee volunteer.” When the email arrived, gently delivering the news that my application to volunteer with the ACR on a committee had not been accepted, my initial reaction was to dismiss it…
In this case report, a patient with voriconazole-induced periostitis exhibits classic symptoms & elevated ALP levels, which quickly resolve following the discontinuation of voriconazole.
The 2024 Rheumatology Research Workshop facilitated educational and relationship-building experiences for early-career and established rheumatology professionals alike.
Marko Radic, PhD, & Georg Schett, MD, were awarded the 2024 Lupus Insight Prize for advances in CAR-T cell therapy.